Skip to main content
SpringerLink
Log in

Preclinical Development of Antisense Therapeutics

  • Chapter
Novel Therapeutics from Modern Biotechnology

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 137))

Abstract

Phosphorothioate oligodeoxynucleotides appear to be an important new class of human therapeutic agents and are the first compounds shown to have the properties required of antisense drugs. They have well-demonstrated antisense modes of drug action, are stable in vitro and have very acceptable half-lives in vivo. When administered by injection, phosphorothioate oligodeoxynucleotides distribute rapidly to tissues and show excellent pharmacokinetics. To date, they have exhibited mild and manageable toxicities at projected and demonstrated therapeutic doses. Phosphorothioate oligodeoxynucleotides are readily taken up by cells in vivo without need for added uptake enhancers. At lengths of 20–21 nucleotides or less, they exhibit messenger RNA (mRNA) affinities sufficient to inhibit gene expression at doses which, in turn, can provide good therapeutic indices and acceptable cost to the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agrawal S (1992) Antisense oligonucleotides as antiviral agents. Trends Biotechnol: 152 - 158

    Google Scholar 

  • Agrawal S, Goodchild J, Civeira MP, Thornton AH, Sarin PS, Zamecnik PC (1988b) Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci USA 85: 7079 – 7083

    Article  CAS  Google Scholar 

  • Agrawal S, Ikeuchi T, Sun D, Sarin PS, Konopka A, Maizel J, Zamecnik PC (1989) Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc Natl Acad Sci USA 86: 7790 – 7794

    Article  PubMed  CAS  Google Scholar 

  • Agrawal S, Tang JT, Brown DM (1990) Analytical study of phosphorothioate analogues of oligodeoxynucleotides using high-performance liquid chromotography. J Chromatogr: 396 – 399

    Google Scholar 

  • Agrawal S, Temsamani J, Galbraith W, Tang J (1995b) Pharmacoketics of antisense oligonucleotides. Clin Pharmacokinet 28: 7 – 16

    Article  CAS  Google Scholar 

  • Agrawal S, Temsamani J, Tang JY (1991) Pharmacokinetics, biodistribution, and stability of oligodeoxynueleotide phosphorothioates in mice. Proc Natl Acad Sci USA 88: 7595 – 7599

    Article  PubMed  CAS  Google Scholar 

  • Agrawal S, Zhang X, Lu Z, Zhao H, Tamburin JM, Yan J, Cai H, Diasio RG, Habus I, Jiang Z, Iyer RP, Yu D, Zhang R (1995a) Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Biochem Pharmacol 50: 571 – 576

    Article  CAS  Google Scholar 

  • Agrawal S, Temsamani J, Galbraith W, Tang J (1995b) Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 28: 7 – 16

    Article  CAS  Google Scholar 

  • Anderson KP, Driver VB, Fox MC, Martin M, Azad RF (1996) Inhibition of cytomegalovirus immediate early gene expression by an antisense oligonucleotide complementary to immediate early RNA. Antimicrob Agents Chemother

    Google Scholar 

  • Azad RF, Driver VB, Tanaka K, Crooke RM, Anderson KP (1993) Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother 37: 1945 – 1954

    PubMed  CAS  Google Scholar 

  • Azad RF, Driver VB, Buckheit R Jr, Anderson KP (1995) Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs. Antiviral Res 28: 101 – 111

    Article  PubMed  CAS  Google Scholar 

  • Bennett CF, Chiang M-Y, Chan H, Shoemaker JEE, Mirabelli CK (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41: 1023 – 1033

    PubMed  CAS  Google Scholar 

  • Bennett CF, Chiang M-Y, Wilson-Lingardo L, Wyatt JR (1994) Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res 22: 3202 – 3209

    Article  PubMed  CAS  Google Scholar 

  • Bennett CF, Condon T, Grimm S, Chan H, Chiang MY (1995) Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J Immunol 152: 3530 – 3540

    Google Scholar 

  • Bennett CF, Kornbrust DJ, Henry SP, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby HI (1997) An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 280: 988 – 1000

    PubMed  CAS  Google Scholar 

  • Bennett RM, Gabor GT, Merritt MM (1985) DNA binding to human leukocytes. Am Soc Clin Invest 76: 2182 – 2190

    Article  CAS  Google Scholar 

  • Bergot BJ, Egan W (1992) Separation of synthetic phosphorothioate oligodeoxy- nucleotides from their oxygenated (phosphodiester) defect species by strong- anion-exchange high-performance liquid chromatography. J Chromatogr: 35 – 42

    Google Scholar 

  • Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ (1992) Selection of single stranded DNA molecules that bind and inhibit human thrombin. Nature 355: 564 – 566

    Article  PubMed  CAS  Google Scholar 

  • Boman NL, Bally M.B, Cullis PR, Mayer LD, Webb MS (1995) Encapsulation of vincristine in liposomes reduces its toxicity and improves its anti-tumor efficacy. J Lipid Res 5: 523 – 541

    CAS  Google Scholar 

  • Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr J- P (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 92: 7297 – 7301

    Article  PubMed  CAS  Google Scholar 

  • Branda RF, Moore AL, Mathews L, McCormack JJ, Zon G (1993) Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem Pharmacol 45: 2037 – 2043

    Article  PubMed  CAS  Google Scholar 

  • Carlson RH, Bozick AH, Fitchett JR (1994) Comparison of the accuracy and precision between capillary gel electrophoresis versus Polyacrylamide gel electrophoresis for assay and impurity determinations of pharmsceutical polynucleotide samples. In Sixth International Symposium on Capillary Electrophoresis, San Diego, CA, USA

    Google Scholar 

  • Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF (1991) Antisense oligonucleotides inhibit intercellular adhesion molecular 1 expression by two distinct mechanisms. J Biol Chem 266: 18162 – 18171

    PubMed  CAS  Google Scholar 

  • Chiasson BJ, Hooper ML, Murphy PR, Robertson HA (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brian. Eur J Pharmacol 227: 451 – 453

    Article  PubMed  CAS  Google Scholar 

  • Cohen AS, Vilenchik M, Dudley JL, Gemborys MW, Bourque AJ (1993) High-performance liquid chromatography and capillary gel electrophoresis as applied to antisense DNA. J Chromatogr: 293 – 301

    Google Scholar 

  • Cornish KG, Iversen P, Smith L, Arneson M, Bayever E (1993) Cardiovascular effects of a phosporothioate oligonucleotide with sequence antisense to p53 in the conscious rhesus monkey. Pharmacol Commun 3: 239 – 247

    CAS  Google Scholar 

  • Cossum PA, Sasmor H, Dellinger D, Troung L, Cummins L, Owens SR, Markham PM, Shea JP, Crooke S (1993) Disposition of the 14c-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J Pharmacol Exp Ther 267: 1181 – 1190

    PubMed  CAS  Google Scholar 

  • Cossum PA, Troung L, Owens SR, Markham PM, Shea JP, Crooke ST (1994) Pharmacokinetics of a 14c-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. J Pharmacol Exp Ther 269: 89 – 94

    PubMed  CAS  Google Scholar 

  • Crooke ST, Bennett CF (1996a) Progress in antisense oligonucleotide therapeutics.Annu Rev Pharmacol Toxicol 36: 107 – 129

    CAS  Google Scholar 

  • Crooke ST, Graham MJ, Zuckerman JE, Brooks D, Conklin BS, Cummins LL, Greig MJ, Guinosso CJ, Kornbrust D, Manoharan M, Sasmor HM, Schleich T, Tivel KL, Griffey RH (1996b) Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther 277: 923 – 937

    CAS  Google Scholar 

  • Dean NM, McKay R (1994) Inhibition of PKC-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 91: 11762 – 11766

    Article  PubMed  CAS  Google Scholar 

  • Dean NM, McKay R, Condon TP, Bennett CF (1994) Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269: 16416 – 16424

    PubMed  CAS  Google Scholar 

  • Diamantstein T, Blistein-Willinger E (1978) Specific binding of poly (I) - poly (C) to the membrane of murine B lymphocyte subsets. Eur J Immunol 8: 896 – 899

    Article  PubMed  CAS  Google Scholar 

  • Diamantstein T, Wagner B, Beyse I, Odenwald MV, Schultz G (1971) Stimulation of humoral antibody formation by poly anions. I. The effect of poly aery lie acid on the primary immune response in mice immunized with sheep red blood cells. Eur J Immunol 1: 335 – 340

    Article  PubMed  CAS  Google Scholar 

  • Feldman MA, Parsons JM, Lee JA, Srivatsa GS (1995) The inhibition effect of phosphorothioate oligonucleotides on the LAL test is reduced through the CaCl2 precipitation of the oligonucleotides. In Sixth International Symposium on Pharmaceutical and Biomedical Analysis, St. Louis, MO, USA

    Google Scholar 

  • Felgner PL, Kumar R, Basava C, Border RC, Hwang-Feigner J-Y (1995) Cationic lipids for intracellular delivery of biologically active molecules. In United States Patent Office. USA

    Google Scholar 

  • Fuhrman LC, Ocheltree TW, Godwin DA, Michniak BB, Bennett CF (1995) Evaluation of several liposomal formulations and preparation techniques for the dermal delivery of phosphorothioate antisense oligonucleotides in hairless mouse skin in vitro. In AAPS Annual Meeting. Miami Beach, FL, USA

    Google Scholar 

  • Galbraith WM, Hobson WC, Giclas PC, Schechter PJ, Agrawal S (1994) Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res Dev 4: 201 – 206

    PubMed  CAS  Google Scholar 

  • Geary RS, Leeds JM, Fitchett J, Burckin T, Truong L, Spainhour C, Creek M, Levin AA (1997) Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-Kinase expression. Drug Metab Dispos 25: 1212 – 1281

    Google Scholar 

  • Glover JM, Leeds JM, Mant TGK, Amin D, Kisner DL, Zuckerman J, Levin A A, Shanahan WR (1997) Phase 1 safety and pharmacokinetic profile of an ICAM-1 antisense oligodeoxynucleotide (ISIS 2302). J Pharmacol Exp Ther 282: 1173 – 1180

    PubMed  CAS  Google Scholar 

  • Henry SP, Larkin R, Novotny WF, Kornbrust DJ (1994) Effects of ISIS 2302, a phosphorothioate oligonucleotide, on in vitro and in vivo coagulation parameters. Pharm Res II:S–353

    Google Scholar 

  • Henry SP, Leeds J, Giclas PC, Gillett NA, Pribble JP, Kornbrust DJ, Levin AA (1996) The toxicity of ISIS 3521, a phosphorothioate oligonucleotide, following intravenous (IV) and subcutaneous (SC) administration in cynomolgus monkeys. Toxicol 30: 112

    Google Scholar 

  • Henry SP, Monteith DK, Levin AA (1997a) Antisense oligonucleotide inhibitors for the treatment of cancer: (2). Toxicological properties of phosphorothioate oligodeoxynucleotides. Anticancer Drug Des 12: 395 – 408

    CAS  Google Scholar 

  • Henry SP, Taylor J, Midgley L, Levin AA, Kornbrust DJ (1997b) Evaluation of the toxicity of ISIS 2302 a phosphorothioate oligonucleotide, in a 4 week study in CS- 1 mice. Antisense Nucleic Acid Drug Dev 7: 473 – 481

    Google Scholar 

  • Hooper ML, Chiasson BJ, Robertson HA (1994) Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect. Neuroscience: 917 – 924

    Google Scholar 

  • Iversen P (1991) In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. Anticancer Drug Des 6: 531 – 538

    PubMed  CAS  Google Scholar 

  • Kambhampati RVB, Chiu Y-Y, Chen CW, Blumenstein JL (1993) Regulatory concerns for the chemistry, manufacturing, and controls of oligonucleotides for use in clinical studies. Antisense Res Dev 3: 405 – 410

    PubMed  CAS  Google Scholar 

  • Katz SM, Browne B, Pham T, Wang ME, Bennett CF, Stepkowski SM, Kahan BD (1995) Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation. Transplant Proc 27: 3214

    PubMed  CAS  Google Scholar 

  • Klinman DM, AE-Kyung Y, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci USA 93: 2879 – 2883

    Article  PubMed  CAS  Google Scholar 

  • Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546 – 549

    Article  PubMed  CAS  Google Scholar 

  • Kumasaka T, Quinlan WM, Doyle NA, Condon TP, Sligh J, Takei F, Beaudet AL, Bennett CF, Doerschuk CM (1996) The role of ICAM-1 in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest

    Google Scholar 

  • Lasic DD, Needham D (1995) The “stealth” liposome: a prototypical biomaterial. Chem Rev 95: 2601 – 2628

    Article  CAS  Google Scholar 

  • Lee K-D, Oh YK, Portnoy DA, Swanson JA (1996) Delivery of macromolecules into cytosol using liposomes containing hemolysin from listeria monocytogenes. J of Biol Chem 271: 7249 – 7252

    Article  CAS  Google Scholar 

  • Leeds JM, Graham MJ, Truong L, Cummins LL (1996b) Quantitation of phosphorothioate oligonucleotides in human plasma. Anal Biochem 235: 36 – 43

    Article  CAS  Google Scholar 

  • Leeds JM, Williams K, Scherrill S, Levin AA, Bistner S, Henry SP (1996a) Potential for retinal accumulation of a phosphorothioate oligonucleotide (ISIS 2922) after intravitreal injection in cynomolgus monkeys. In Society of Toxicology Annual Meeting. Anaheim, CA, USA

    Google Scholar 

  • Lewis JG, Lin K-Y, Kothavale A, Flanagan WM, Matteucci MD (1996) A serum- resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA 93: 3176 – 3181

    Article  PubMed  CAS  Google Scholar 

  • Lisziewicz J, Sun D, Metelev V, Zamecnik P, Gallo RC, Agrawal S (1993) Long-term treatment of human immunodeficiency virus-infected cells with anstisense oligonucleotide phosphorothioates. Proc Natl Acad Sci USA 30: 3860 – 3864

    Article  Google Scholar 

  • Mclntyre KW, Lombard-Gillooly K, Perez JR, Kunsch C, Sarmiento UM, Larigan JD, Landreth KT, Narayanan R (1993) A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor nf-kb p65 causes sequence- specific immune stimulation. Antisense Res Dev 3: 309 – 322

    Google Scholar 

  • Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM (1992) Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 267: 19954 – 19962

    PubMed  CAS  Google Scholar 

  • Nestle FO, Mitra RS, Bennett CF, Chan H, Nickoloff BJ (1994) Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol 103: 569 – 575

    Article  PubMed  CAS  Google Scholar 

  • Oberbauer R, Schreiner GF, Meyer TW (1995) Renal uptake of an 18-mer phosphorothioate oligonucleotide. Kidney Int 48: 1226 – 1232

    Article  PubMed  CAS  Google Scholar 

  • Ocheltree TW, Fuhrman LC, Mehta R, Michniak BB, Shah JC (1996) Epidermal and dermal penetration of anionic and zwitterionic liposomally encapsulated antisense oligonucleotides into hairless mouse skin. In Amer Assoc of Pharm Scientists, ed. R. Mehta. Seattle, WA, USA

    Google Scholar 

  • Plenat F, Klein-Monhoven N, Marie B, Vignaud J-M, Duprez A (1994) Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. Am J Pathol 147: 124 – 135

    Google Scholar 

  • Rappaport J, Hanss B, Kopp JB, Copeland TD, Bruggeman LA, Coffman TM, Klotman PE (1995) Transport of phosphorothioate oligonucleotides in kidney implications for molecular therapy. Kidney Int 47: 1462 – 1469

    Article  PubMed  CAS  Google Scholar 

  • Ravikumar VT, Andrade M, Wyrzykiewicz TK, Scozzari A, Cole DL (1995) Large- scale synthesis of oligodeoxyribonucleotide phosphorothioate using controlled- pore glass as support. Nucleosides Nucleotides 14: 1219 – 1226

    Article  CAS  Google Scholar 

  • Rosenberger RD (1989) Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 87:2S–3S

    Google Scholar 

  • Saijo Y, Perlaky L, Wang H, Busch H (1994) Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Oncol Res 6: 243 – 249

    PubMed  CAS  Google Scholar 

  • Sands H, Gorey-Feret LJ, Cocuzza AJ, Hobbs FW, Chidester D, Trainor GL (1994) Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and phosphorothioate. Mol Pharmacol 45: 932 – 943

    PubMed  CAS  Google Scholar 

  • Sarmiento UM, Perez JR, Becker JM, Narayanan R (1994) In vivo toxicological effects of rei A antisense phosphorothioates in CD-1 mice. Antisense Res Dev 4: 99 – 107

    PubMed  CAS  Google Scholar 

  • Sawai K, Miyao T, Takakura Y, Hashida M (1995) Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney. Antisense Res Dev 5: 279 – 287

    PubMed  CAS  Google Scholar 

  • Schuette J, Srivatsa GS, Cole DL (1994) Development and validation of a method for routine base composition analysis of phosphorothioate oligonucleotides. J Pharm Biomed Anal 12: 1345 – 1353

    Article  PubMed  CAS  Google Scholar 

  • Schuette J, Pieles U, Maleknia S, Srivatsa GS, Cole DL, Moser HE, Afeyan NB (1995) Sequence analysis of phosphorothioate oligonucleotides via matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Pharm Biomed Anal 13: 1195 – 1203

    Article  PubMed  CAS  Google Scholar 

  • Srinivasan SK, Iversen P (1995) Review of in vivo pharmacokinetics and toxicology of piiosphorothioate oligonucleotides. J Clin Lab Anal 9: 129 – 137

    Article  PubMed  CAS  Google Scholar 

  • Srivatsa GS, Batt M, Schuette J, Carlson R, Fitchett J, Lee C, Cole DL (1994) Quantitative capillary gel electrophoresis (QCGE) assay of phosphorothioate oligonucleotide in pharmaceutical formulations. J Chromatogr 680: 469 – 477

    Article  CAS  Google Scholar 

  • Srivatsa GS, Klopehin P, Batt M, Feldman M, Carlson RH, Cole DL (1997) Selectivity of anion exchange chromatography and capillary gel electrophoresis for the analysis of phosphorothioate oligonucleotides. J Pharm Biomed Anal 16: 619 – 630

    Article  PubMed  CAS  Google Scholar 

  • Stein CA (1995) Does antisense exist? Nat Med 1: 1119 – 1121

    Article  PubMed  CAS  Google Scholar 

  • Stein CA, Cheng Y-C (1993) Antisense oligonucleotides as therapeutic agents-Is the bullet really magical? Science 261: 1004 – 1012

    Article  PubMed  CAS  Google Scholar 

  • Stein CA, Krieg AM (1994) Problems in intrepretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev 4: 67 – 69

    PubMed  CAS  Google Scholar 

  • Stein CA, Neckers M, Nair BC, Mumbauer S, Hoke G, Pal R (1991) Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J Acquir Immune Defic Syndr 4: 686 – 693

    PubMed  CAS  Google Scholar 

  • Stepkowski SM, Tu Y, Condon TP, Bennett CF (1994) Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppresive modalities. J Immunol 10: 5336 – 5346

    Google Scholar 

  • Suska A, Grajkowski A, Wilk A, Uznanski B, Blaszczyk J, Wieczorek M, Stec WJ (1993) Antisense oligonucleotides: Stereocontrolled synthesis of phosphoro¬thioate oligonucleotides. Pure Appi Chem 65: 707 – 714

    Article  CAS  Google Scholar 

  • Szklarczyk A, Kaczmarek L (1995) Antisense oligodeoxyribonucleotides: Stability and distribution after intracerebral injection into rat brain. J Neurosci Methods: 181 – 187

    Google Scholar 

  • Talmadge JE, Adams J, Phillips H, Collins M, Lenz B, Schneider M, Schlick E, Ruffmann R, Wiltrout RH, Chirigos MA (1985) Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymenthycellulosel. Cancer Res 45: 1058 – 1065

    PubMed  CAS  Google Scholar 

  • Temsamani J, Tang J-Y, Padmapriya A, Kubert M, Agrawal S (1993) Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphoro- thioates in mice. Antisense Research and Development 3: 277 – 284

    PubMed  CAS  Google Scholar 

  • Warren WJ, Velia G (1993) Analysis of synthetic oligodeoxyribonucleotides by capillary gel electrophoresis and anion-exchange HPLC. BioTechniques 14: 598 – 606

    PubMed  CAS  Google Scholar 

  • Watson PH, Pon RT, Shiu RPC (1992) Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide. Exp Cell Res 202: 391 – 397

    Article  PubMed  CAS  Google Scholar 

  • Weiss B, Zhou L-W, Zhang S-P, Qin Z-H (1993) Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messanger RNA. Neuroscience 55: 607 – 612

    Article  PubMed  CAS  Google Scholar 

  • Whitesell L, Geselowitz D, Chavany C, Fahmy B, Walbridge S, Alger JR, Neckers LM (1993) Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc Natl Acad Sci USA 90: 4665 – 4669

    Article  PubMed  CAS  Google Scholar 

  • Wu-Pong S, Weiss TL, Hunt AC (1994) Antisense c-mycoligonucleotide cellular uptake and activity. Antisense Res Dev 4: 155 – 163

    PubMed  CAS  Google Scholar 

  • Wyrzykiewicz TK, Cole DL (1994) Sequencing of oligonucleotide phosphorothioates based on solid-supported desulfurization. Nucleic Acids Res 22: 2667 – 2669

    Article  PubMed  CAS  Google Scholar 

  • Wyrzykiewicz TK, Cole DL (1995) Stereo-reproducibility of the phosphoramidite method in the synthesis of oligonucleotide phosphorothioates. Bioorg Chem 23: 33 – 41

    Article  CAS  Google Scholar 

  • Yamamoto T, Yamamoto S, Kataoka T, Tokunaga T (1994) Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Res Dev: 119 – 122

    Google Scholar 

  • Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Martuza RL, RI G (1996Submitted) Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxy nucleo tide. Mol Pharmacol 50:236–242

    Google Scholar 

  • Zhou L-W, Zhang S-P, Qin Z-H, Weiss B (1994) In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptors in mouse striatum. J Pharmacol Exp Ther 268: 1015 – 1023

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. A. Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. P. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. F. Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. L. Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. E. Hardee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. S. Srivatsa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Parke-Davis Pharmaceutical Research, 2800 Plymouth Road, 48105, Ann Arbor, MI, USA

    Dale L. Oxender Ph.D. Cell Biology  & Leonard E. Post Ph.D. (Vice President, Discovery Research) &  (Vice President, Discovery Research)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Levin, A.A., Henry, S.P., Bennett, C.F., Cole, D.L., Hardee, G.E., Srivatsa, G.S. (1999). Preclinical Development of Antisense Therapeutics. In: Oxender, D.L., Post, L.E. (eds) Novel Therapeutics from Modern Biotechnology. Handbook of Experimental Pharmacology, vol 137. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59990-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59990-3_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65927-3

  • Online ISBN: 978-3-642-59990-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation